Stanford
Despite Overall Survival Miss, Singapore Researchers Champion Success of Global Cell Therapy Trial
Premium
The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell therapy to date.
Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith
Foresight said that Roche's asserted trade secrets were not secret and that the technologies at the heart of the claim are fundamentally different.
Stanford Medicine Laboratory for Cell and Gene Medicine Awarded Grant for CAR T-Cell Platform
The lab will use the G-Rex platform to manufacture a CAR T-cell therapy for a Phase I clinical trial.
Neurologists treating patients who present with a small stroke or transient ischemic attack are now able to get PGx results to inform their prescription of Plavix within 24 hours.
Roche Sues Foresight Diagnostics, Stanford Over Cancer Detection Technology
Roche has accused Foresight's founders of misusing technology Roche acquired in 2015 in funding their own startup.
Jan 19, 2023